Coupon
After the Fall
by Patricia Gussin


Overview - An action-packed medical thriller

A tragic accident ends Laura Nelson's career as a surgeon. After accepting a position as Vice President for Research in a large pharmaceutical company, Laura works to finalize the imminent approval of the company's groundbreaking new drug.  Read more...


 
Hardcover
  • $26.95

Add to Cart + Add to Wishlist

In Stock

FREE Shipping for Club Members
 
> Check In-Store Availability

In-Store pricing may vary

 
 
New & Used Marketplace 26 copies from $2.99
 
 
 
 

More About After the Fall by Patricia Gussin
 
 
 
Overview
An action-packed medical thriller

A tragic accident ends Laura Nelson's career as a surgeon. After accepting a position as Vice President for Research in a large pharmaceutical company, Laura works to finalize the imminent approval of the company's groundbreaking new drug. But Jake Harter, a malicious Food and Drug Administration employee, cannot let that happen. He is obsessed with Adawia Abdul, the beautiful Iraqi scientist who discovered the drug. As soon as the drug is approved, Adawia will collect a substantial bonus and reluctantly return to replace her dying father, the lead scientist in Saddam Hussein's bioweapon program. As Hussein's henchmen apply brutal pressure to assure Dr. Abdul's speedy return to Iraq, Harter uses his influence to stall the drug's approval. If Laura gets in his way, he will eliminate her as he has her predecessor and his own wife.


 
Details
  • ISBN-13: 9781608091270
  • ISBN-10: 1608091279
  • Publisher: Oceanview Publishing
  • Publish Date: January 2015
  • Page Count: 368
  • Dimensions: 9.37 x 6.41 x 1.22 inches
  • Shipping Weight: 1.41 pounds

Series: Laura Nelson #4

Related Categories

Books > Fiction > Romance - Suspense
Books > Fiction > Thrillers - Suspense

 
Publishers Weekly Reviews

Publishers Weekly® Reviews

  • Reviewed in: Publishers Weekly, page .
  • Review Date: 2014-11-24
  • Reviewer: Staff

Dr. Laura Nelson, chief of surgery at Tampa City Hospital (Fla.), reluctantly seeks a new career after suffering a serious hand injury in Gussin’s superior fourth and final series thriller (after 2012’s Weapons of Choice), set a year after the Gulf War. Laura agrees to become an executive at Keystone Pharma, a company about to release a wonderful new drug, Immunone, for which she helped organize the clinical trials. Meanwhile, FDA project manager Jake Harter is desperate to keep Immunone from being approved, for his own nefarious reasons. Jake is also willing to hide vital data and commit murder to keep his lover, Iraqi researcher Adawia Abdul, from leaving the U.S. Meanwhile, Saddam Hussein’s minions are pressuring Adawia to return home so that she can create bioweapons. Gussin deftly resolves the various plotlines at the climax. Along the way, she vividly depicts her characters’ interior lives, especially Jake’s slide into monomania as he collides with the determined, clear-headed Laura. (Jan.)

 
BAM Customer Reviews